Bloomfield Industries, one of the five companies licensed to sell medical marijuana in New York, is being acquired by MedMen, a California-based marijuana management and consulting firm.
The change in ownership comes just two days after New York State’s medical marijuana program marked its first year, amid cries from executives that the market is not viable and reassurances from the state Department of Health that the program remains on course. 
Bloomfield had been facing “financial constraints” for at least the last six months, forcing the company to skip payments to some vendors and entertain offers from several investors, including MedMen, which has a $100 million venture capital arm.
Read more at Politico New York
Announcements
Vacancies
US: MedMen acquires troubled New York MMJ licensee
Publication date:
Receive the daily newsletter in your email for free | Click here
Other news in this sector:
- 2023-11-28 US (MA): Cannabis worker’s death reignites talks for improved workplace safety rules
- 2023-11-22 Strategies for maximizing your greenhouse efficiency in winter
- 2023-11-21 Attention to water at start of new cultivation
- 2023-11-20 Plant protects next generation via soil
- 2023-11-15 CAN: Aurora Sun greenhouse might be growing veggies and flowers by 2024
- 2023-11-03 Newly discovered compound might be the smelly one
- 2023-11-02 US (CA): East Bay school to offer cannabis education courses at Cal State University
- 2023-11-01 The importance of terpenes may be overemphasized, study suggests
- 2023-11-01 New global reporting tool keeps farmers on track
- 2023-10-30 Scandinavia and its green ideology
- 2023-10-27 US (NJ): Growing cannabis in New Jersey? Not as easy as you may think
- 2023-10-24 A report on the use of ozone over a period of three years
- 2023-10-24 US (CA): Rare cannabis discovered 50 years ago is available in California
- 2023-10-23 “Research can help cannabis companies to reduce costs”
- 2023-10-20 The influence of pruning, topping, and defoliation on the morphology of cannabis
- 2023-10-20 US: Moldy cannabis allegations draw ire of some Missouri operators
